The future of cerebral organoids in drug discovery.

Abstract excerpt

Until the discovery of human embryonic stem cells and human induced pluripotent stem cells, biotechnology companies were severely limited in the number of human tissues that they could model in large-scale in vitro studies. Until this point, companies have been limited to immortalized cancer lines or a small number of primary cell types that could be extracted and expanded. Nowadays, protocols continue to be...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cerebral Cortex
• Share to Drug Discovery
• Share to Drugs, Investigational